Cocrystal Pharma, Inc.COCPNASDAQ
Loading
Cost of Revenue Over TimeContracting
Percentile Rank47
3Y CAGR-51.4%
5Y CAGR-25.1%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
-51.4%/yr
vs +296.8%/yr prior
5Y CAGR
-25.1%/yr
Recent deceleration
Acceleration
-348.2pp
Decelerating
Percentile
P47
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.42M | -88.7% |
| 2024 | $12.54M | -17.4% |
| 2023 | $15.17M | +22.4% |
| 2022 | $12.39M | +40.9% |
| 2021 | $8.79M | +45.7% |
| 2020 | $6.03M | +50.7% |
| 2019 | $4.00M | +7908.0% |
| 2018 | $50000.00 | -50.5% |
| 2017 | $101000.00 | -49.8% |
| 2016 | $201000.00 | - |